Literature DB >> 33488507

Multi-Modal Imaging in Down's Syndrome: Maximizing Utility Through Innovative Neuroimaging Approaches.

Stephanie S G Brown1, Elijah Mak1,2, Shahid Zaman1.   

Abstract

In recent decades, the field of neuroimaging has experienced a surge of popularity and innovation which has led to significant advancements in the understanding of neurological disease, if not immediate clinical translation. In the case of Down's syndrome, a complex interplay of neurodevelopmental and neurodegenerative processes occur as a result of the trisomy of chromosome 21. The substantial potential impact of improved clinical intervention and the limited research under-taken to date make it a prime candidate for longitudinal neuroimaging-based study. However, as with a multitude of other multifaceted brain-based disorders, singular utilization of lone modality imaging has limited interpretability and applicability. Indeed, a present challenge facing the neuroimaging community as a whole is the methodological integration of multi-modal imaging to enhance clinical understanding. This review therefore aims to assess the current literature in Down's syndrome utilizing a multi-modal approach with regards to improvement upon consideration of a single modality. Additionally, we discuss potential avenues of future research that may effectively combine structural, functional and molecular-based imaging techniques for the significant benefit of the understanding of Down's syndrome pathology.
Copyright © 2021 Brown, Mak and Zaman.

Entities:  

Keywords:  Alzheimer's disease; Down's syndrome (DS); MRI; PET; multi-modal; neuroimaging

Year:  2021        PMID: 33488507      PMCID: PMC7817620          DOI: 10.3389/fneur.2020.629463

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  40 in total

1.  Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.

Authors:  Marwan N Sabbagh; Kewei Chen; Joseph Rogers; Adam S Fleisher; Carolyn Liebsack; Dan Bandy; Christine Belden; Hillary Protas; Pradeep Thiyyagura; Xiaofen Liu; Auttawut Roontiva; Ji Luo; Sandra Jacobson; Michael Malek-Ahmadi; Jessica Powell; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2015-04-04       Impact factor: 21.566

2.  Frontal white matter integrity in adults with Down syndrome with and without dementia.

Authors:  David Powell; Allison Caban-Holt; Gregory Jicha; William Robertson; Roberta Davis; Brian T Gold; Frederick A Schmitt; Elizabeth Head
Journal:  Neurobiol Aging       Date:  2014-02-04       Impact factor: 4.673

3.  Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Neuropathol Appl Neurobiol       Date:  1984 May-Jun       Impact factor: 8.090

4.  Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.

Authors:  Benjamin L Handen; Ann D Cohen; Umapathy Channamalappa; Peter Bulova; Sheila A Cannon; William I Cohen; Chester A Mathis; Julie C Price; William E Klunk
Journal:  Alzheimers Dement       Date:  2012-11       Impact factor: 21.566

Review 5.  Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome.

Authors:  Filippo Caraci; M Florencia Iulita; Rowan Pentz; Lisi Flores Aguilar; Chiara Orciani; Concetta Barone; Corrado Romano; Filippo Drago; A Claudio Cuello
Journal:  Eur J Pharmacol       Date:  2017-10-05       Impact factor: 4.432

Review 6.  Key clinical benefits of neuroimaging at 7T.

Authors:  Siegfried Trattnig; Elisabeth Springer; Wolfgang Bogner; Gilbert Hangel; Bernhard Strasser; Barbara Dymerska; Pedro Lima Cardoso; Simon Daniel Robinson
Journal:  Neuroimage       Date:  2016-11-13       Impact factor: 6.556

7.  In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.

Authors:  Elijah Mak; Richard A I Bethlehem; Rafael Romero-Garcia; Simon Cervenka; Timothy Rittman; Silvy Gabel; Ajenthan Surendranathan; Richard W Bevan-Jones; Luca Passamonti; Patricia Vázquez Rodríguez; Li Su; Robert Arnold; Guy B Williams; Young T Hong; Tim D Fryer; Franklin I Aigbirhio; James B Rowe; John T O'Brien
Journal:  Alzheimers Dement (Amst)       Date:  2018-09-17

8.  Cortical patterning of abnormal morphometric similarity in psychosis is associated with brain expression of schizophrenia-related genes.

Authors:  Sarah E Morgan; Jakob Seidlitz; Kirstie J Whitaker; Rafael Romero-Garcia; Nicholas E Clifton; Cristina Scarpazza; Therese van Amelsvoort; Machteld Marcelis; Jim van Os; Gary Donohoe; David Mothersill; Aiden Corvin; Andrew Pocklington; Armin Raznahan; Philip McGuire; Petra E Vértes; Edward T Bullmore
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-19       Impact factor: 11.205

9.  Down syndrome: Distribution of brain amyloid in mild cognitive impairment.

Authors:  David B Keator; Michael J Phelan; Lisa Taylor; Eric Doran; Sharon Krinsky-McHale; Julie Price; Erin E Ballard; William C Kreisl; Christy Hom; Dana Nguyen; Margaret Pulsifer; Florence Lai; Diana H Rosas; Adam M Brickman; Nicole Schupf; Michael A Yassa; Wayne Silverman; Ira T Lott
Journal:  Alzheimers Dement (Amst)       Date:  2020-04-17

Review 10.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

View more
  1 in total

Review 1.  Quantitative Structural Brain Magnetic Resonance Imaging Analyses: Methodological Overview and Application to Rett Syndrome.

Authors:  Tadashi Shiohama; Keita Tsujimura
Journal:  Front Neurosci       Date:  2022-04-05       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.